Identification of conserved RNA secondary structures at influenza B and C splice sites reveals similarities and differences between influenza A, B, and C

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Dela Moss, Lumbini I ^a   Moss, Walter N ^a   Turner, Douglas H ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Bioinformatics; Influenza; RNA; Secondary structure; Splice sites; Splicing

Indexed keywords

RNA VIRUSES;

VIRUS RNA;

AMINO ACID SEQUENCE; ARTICLE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; CONFORMATION; CONSENSUS SEQUENCE; GENETICS; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INFLUENZA VIRUS C; MUTATION; OPEN READING FRAME; RNA SPLICING; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; START CODON;

AMINO ACID SEQUENCE; CODON, INITIATOR; COMPUTATIONAL BIOLOGY; CONSENSUS SEQUENCE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZAVIRUS C; MODELS, MOLECULAR; MUTATION; NUCLEIC ACID CONFORMATION; OPEN READING FRAMES; RNA SPLICE SITES; RNA, VIRAL; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPECIES SPECIFICITY;

EID: 84892150392     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-22     Document Type: Article

References (115)

1. Infleunza-associated hospitilizations in the United States. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K, JAMA 2004 292 1333 1340 10.1001/jama.292.11.1333 15367555
2. Centers for Disease Control and Prevention. Estimates of deaths associated with seasonal influenza-United States, 1976-2007. Thompson MG, Shay DK, Zhou H, Bridges CB, Cheng PY, Burns E, Bresee JS, Cox NJ, MMWR 2010 59 1057 1062 20798667
3. The biology of influenza viruses. Bouvier NM, Palese P, Vaccine 2008 26 49 D53 19230160
4. McCauley JW, Hongo S, Kaverin NV, Kochs G, Lamb RA, Matrosovich MN, Perez DR, Palese P, Presti RM, Rimstad E, Virus taxonomy: classification and nomenclature of viruses: Ninth Report of the International Committee on Taxonomy of Viruses San Diego: Elsevier Academic Press, King AMQ, Lefkowitz E, Adams MJ, Carstens EB, 1 2012 749 761
5. Host-range barrier of influenza A viruses. Ito T, Kawaoka Y, Vet Microbiol 2000 74 1-2 71 75 10799779
6. Influenza. Lamb RA, Encyclopedia of Virology Academic Press, Mahy BWJ, van Regenmortel MHV, 3 2008 95 104
7. The evolution of human influenza viruses. Hay AJ, Gregory V, Douglas AR, Lin YP, Philos Trans R Soc Lond B Biol Sci 2001 356 1416 1861 1870 11779385
8. Shaw ML, Palese P, Orthomyxoviruses: Molecular Biology In: Encyclopedia of Virology. Third Edition edn 2008 483 489
9. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, Nerome K, Virology 1990 175 1 59 68 10.1016/0042-6822(90)90186-U 2309452
10. The economic value of a quadrivalent versus trivalent influenza vaccine. Lee BY, Bartsch SM, Willig AM, Vaccine 2012 30 52 7443 7446 10.1016/j.vaccine. 2012.10.025 23084849
11. The rationale for quadrivalent influenza vaccines. Ambrose CS, Levin MJ, Human Vaccines & Immunotherapeutics 2012 8 1 81 88 10.4161/hv.8.1.17623 22252006
12. Viral IRES RNA structures and ribosome interactions. Kieft JS, Trends Biochem Sci 2008 33 6 274 283 10.1016/j.tibs.2008.04.007 18468443
13. Functional interactions in internal translation initiation directed by viral and cellular IRES elements. Martinez-Salas E, Ramos R, Lafuente E, Lopez de Quinto S, J Gen Virol 2001 82 973 984 11297672
14. RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. Clyde K, Harris E, J Virol 2006 80 5 2170 2182 10.1128/JVI.80.5.2170-2182.2006 16474125
15. RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1. Clever J, Sassetti C, Parslow TG, J Virol 1995 69 2101 2109 7884856
16. The role of a metastable RNA secondary structure in hepatitis delta virus genotype III RNA editing. Linnstaedt SD, Kasprzak WK, Shapiro BA, Casey JL, RNA 2006 12 8 1521 1533 10.1261/rna.89306 16790843
17. RNA structure modulates splicing efficiency at the human immunodeficiency virus type 1 major splice donor. Abbink TE, Berkhout B, J Virol 2008 82 6 3090 3098 10.1128/JVI.01479-07 18160437
18. Solution structure of the pseudo-5' splice site of a retroviral splicing suppressor. Cabello-Villegas J, Giles KE, Soto AM, Yu P, Mougin A, Beemon KL, Wang YX, RNA 2004 10 9 1388 1398 10.1261/rna.7020804 15317975
19. Limited complementarity between U1 snRNA and a retroviral 5' splice site permits its attenuation via RNA secondary structure. Zychlinski D, Erkelenz S, Melhorn V, Baum C, Schaal H, Bohne J, Nucleic Acids Res 2009 37 22 7429 7440 10.1093/nar/gkp694 19854941
20. RNA pseudoknots and the regulation of protein synthesis. Brierley I, Gilbert RJ, Pennell S, Biochem Soc Trans 2008 36 Pt 4 684 689 18631140
21. RNA pseudoknots: folding and finding. Liu B, Mathews DH, Turner DH, F1000 Biology Reports 2010 2 8 20495679
22. Pseudoknots: RNA structures with diverse functions. Staple DW, Butcher SE, PLoS Biol 2005 3 6 213 10.1371/journal.pbio.0030213 15941360
23. Viral RNA pseudoknots: versatile motifs in gene expression and replication. Brierley I, Pennell S, Gilbert RJ, Nat Rev Microbiol 2007 5 8 598 610 10.1038/nrmicro1704 17632571
24. Frameshifting RNA pseudoknots: structure and mechanism. Giedroc DP, Cornish PV, Virus Res 2009 139 2 193 208 10.1016/j.virusres.2008.06.008 18621088
25. The 3' and 5'-terminal sequences of influenza A, B, and C virus RNA segments are highly conserved and show partial inverted complementarity. Desselberger U, Racaniello VR, Zazra JJ, Palese P, Gene 1980 8 315 328 10.1016/0378-1119(80)90007-4 7358274
26. Promoter elements in the influenza vRNA terminal structure. Flick R, Neumann G, Hoffman E, Neumeier E, Hobom G, RNA 1996 2 1046 1057 8849780
27. Biophysical analysis of influenza A virus RNA promoter at physiological temperatures. Noble E, Mathews DH, Chen JL, Turner DH, Takimoto T, Kim B, J Biol Chem 2011 286 26 22965 22970 10.1074/jbc.M111.239509 21555520
28. Secondary structure of the panhandle RNA of influenza virus A studied by NMR spectroscopy. Cheong H, Cheong C, Choi B, Nucleic Acids Res 1996 24 4197 4201 10.1093/nar/24.21.4197 8932372
29. The RNA polymerase of influenza A virus is stabilized by interaction with its viral RNA promoter. Brownlee GG, Sharps JL, J Virol 2002 76 14 7103 7113 10.1128/JVI.76.14.7103-7113.2002 12072510
30. Mutational analysis of the influenza virus cRNA promoter and identification of nucleotides critical for replication. Crow M, Deng T, Addley M, Brownlee GG, J Virol 2004 78 12 6263 6270 10.1128/JVI.78.12.6263-6270.2004 15163719
31. Folding and finding RNA secondary structure. Mathews DH, Moss WN, Turner DH, Cold Spring Harb Perspect Biol 2010 2 12 003665 20685845
32. Advances in RNA structure prediction from sequence: new tools for generating hypotheses about viral RNA structure-function relationships. Schroeder S, J Virol 2009 83 6326 6334 10.1128/JVI.00251-09 19369331
33. De novo prediction of structured RNAs from genomic sequences. Gorodkin J, Hofacker IL, Torarinsson E, Yao Z, Havgaard JH, Ruzzo WL, Trends Biotechnol 2010 28 1 9 19 10.1016/j.tibtech.2009.09.006 19942311
34. A comparative method for finding and folding RNA secondary structures within protein-coding regions. Pedersen JS, Meyer IM, Forsberg R, Simmonds P, Hein J, Nucleic Acids Res 2004 32 16 4925 4936 10.1093/nar/gkh839 15448187
35. Global or local? Predicting secondary structure and accessibility in mRNAs. Lange SJ, Maticzka D, Mohl M, Gagnon JN, Brown CM, Backofen R, Nucleic Acids Res 2012 40 12 5215 5226 10.1093/nar/gks181 22373926
36. Protein-coding structured RNAs: A computational survey of conserved RNA secondary structures overlapping coding regions in drosophilids. Findeiss S, Engelhardt J, Prohaska SJ, Stadler PF, Biochimie 2011 93 11 2019 2023 10.1016/j.biochi.2011.07.023 21835221
37. Identification of potential conserved RNA secondary structure throughout influenza A coding regions. Moss WN, Priore SF, Turner DH, RNA 2011 17 6 991 1011 10.1261/rna.2619511 21536710
38. Mapping of conserved RNA secondary structures predicts thousands of functional noncoding RNAs in the human genome. Washietl S, Hofacker IL, Lukasser M, Huttenhofer A, Stadler PF, Nat Biotechnol 2005 23 11 1383 1390 10.1038/nbt1144 16273071
39. Fast and reliable prediction of noncoding RNAs. Washietl S, Hofacker IL, Stadler PF, Proc Natl Acad Sci USA 2005 102 7 2454 2459 10.1073/pnas.0409169102 15665081
40. RNAz 2.0: improved noncoding RNA detection. Gruber AR, Findeiss S, Washietl S, Hofacker IL, Stadler PF, Pac Symp Biocomput 2010 15 69 79
41. Structural constraints on RNA virus evolution. Simmonds P, Smith DB, J Virol 1999 73 7 5787 5794 10364330
42. Detailed mapping of RNA secondary structures in core and NS5B-encoding region sequences of hepatitis C virus by RNase cleavage and novel bioinformatic prediction methods. Tuplin A, Evans DJ, Simmonds P, J Gen Virol 2004 85 Pt 10 3037 3047 15448367
43. An RNA conformational shift in recent H5N1 influenza A viruses. Gultyaev AP, Heus HA, Olsthoorn RC, Bioinformatics 2007 23 3 272 276 10.1093/ bioinformatics/btl559 17090581
44. A family of non-classical pseudoknots in influenza A and B viruses. Gultyaev AP, Olsthoorn RC, RNA Biol 2010 7 2 125 129 10.4161/rna.7.2.11287 20200490
45. Importance of mRNA secondary structural elements for the expression of influenza virus genes. Ilyinskii PO, Schmidt T, Lukashev D, Meriin AB, Thoidis G, Frishman D, Shneider AM, OMICS 2009 13 5 421 430 10.1089/omi.2009.0036 19594376
46. The influenza virus resource at the National Center for Biotechnology Information. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J, Lipman D, J Virol 2008 82 2 596 601 10.1128/JVI.02005-07 17942553
47. SeaView version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Gouy M, Guindon S, Gascuel O, Mol Biol Evol 2010 27 2 221 224 10.1093/molbev/msp259 19854763
48. SEAVIEW and PHYLO-WIN: two graphic tools for sequence alignment and molecular phylogeny. Galtier N, Gouy M, Gautier C, Comput Appl Biosci 1996 12 6 543 548 9021275
49. Clustal W and Clustal X version 2.0. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, et al. Bioinformatics 2007 23 21 2947 2948 10.1093/bioinformatics/btm404 17846036
50. MAFFT version 5: improvement in accuracy of multiple sequence alignment. Katoh K, Kuma K, Toh H, Miyata T, Nucleic Acids Res 2005 33 2 511 518 10.1093/nar/gki198 15661851
51. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Katoh K, Misawa K, Kuma K, Miyata T, Nucleic Acids Res 2002 30 14 3059 3066 10.1093/nar/gkf436 12136088
52. RNAalifold: improved consensus structure prediction for RNA alignments. Bernhart SH, Hofacker IL, Will S, Gruber AR, Stadler PF, BMC Bioinformatics 2008 9 474 10.1186/1471-2105-9-474 19014431
53. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. Mathews DH, Sabina J, Zuker M, Turner DH, J Mol Biol 1999 288 5 911 940 10.1006/jmbi.1999.2700 10329189
54. RNAstructure: software for RNA secondary structure prediction and analysis. Reuter JS, Mathews DH, BMC Bioinformatics 2010 11 129 10.1186/1471-2105-11-129 20230624
55. Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure. Mathews DH, Disney MD, Childs JL, Schroeder SJ, Zuker M, Turner DH, Proc Natl Acad Sci U S A 2004 101 19 7287 7292 10.1073/pnas.0401799101 15123812
56. Revolutions in RNA secondary structure prediction. Mathews DH, J Mol Biol 2006 359 3 526 532 10.1016/j.jmb.2006.01.067 16500677
57. Using an RNA secondary structure partition function to determine confidence in base pairs predicted by free energy minimization. Mathews DH, RNA 2004 10 8 1178 1190 10.1261/rna.7650904 15272118
58. The MC-Fold and MC-Sym pipeline infers RNA structure from sequence data. Parisien M, Major F, Nature 2008 452 7183 51 55 10.1038/nature06684 18322526
59. DotKnot: pseudoknot prediction using the probability dot plot under a refined energy model. Sperschneider J, Datta A, Nucleic Acids Res 2010 38 7 103 10.1093/nar/gkq021 20123730
60. Thermodynamic parameters for an expanded nearest-neighbor model for formation of RNA duplexes with Watson-Crick base pairs. Xia T, SantaLucia J Jr, Burkard ME, Kierzek R, Schroeder SJ, Jiao X, Cox C, Turner DH, Biochemistry 1998 37 42 14719 14735 10.1021/bi9809425 9778347
61. Predicting RNA pseudoknot folding thermodynamics. Cao S, Chen SJ, Nucleic Acids Res 2006 34 9 2634 2652 10.1093/nar/gkl346 16709732
62. Predicting structures and stabilities for H-type pseudoknots with interhelix loops. Cao S, Chen SJ, RNA 2009 15 4 696 706 10.1261/rna.1429009 19237463
63. Epidemiology of influenza C virus in man: multiple evolutionary lineages and low rate of change. Buonagurio DA, Nakada S, Fitch WM, Palese P, Virology 1986 153 1 12 21 10.1016/0042-6822(86)90003-6 2943076
64. Comparison of the mutation rates of human influenza A and B viruses. Nobusawa E, Sato K, J Virol 2006 80 7 3675 3678 10.1128/JVI.80.7.3675-3678.2006 16537638
65. Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses. Yamashita M, Krystal M, Fitch WM, Palese P, Virology 1988 163 1 112 122 10.1016/0042-6822(88) 90238-3 3267218
66. Evolutionary changes in influenza B are not primarily governed by antibody selection. Air GM, Gibbs AJ, Laver WG, Webster RG, Proc Natl Acad Sci U S A 1990 87 10 3884 3888 10.1073/pnas.87.10.3884 2378639
67. Origin and evolution of influenza virus hemagglutinin genes. Suzuki Y, Nei M, Mol Biol Evol 2002 19 4 501 509 10.1093/oxfordjournals.molbev.a004105 11919291
68. Influenza B and C virus NEP (NS2) proteins possess nuclear export activities. Paragas J, Talon J, O'Neill RE, Anderson DK, Garcia-Sastre A, Palese P, J Virol 2001 75 16 7375 7383 10.1128/JVI.75.16.7375-7383.2001 11462009
69. NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome. Robb NC, Smith M, Vreede FT, Fodor E, J Gen Virol 2009 90 Pt 6 1398 1407 19264657
70. Role of RNA structure in regulating pre-mRNA splicing. Warf MB, Berglund JA, Trends Biochem Sci 2010 35 3 169 178 10.1016/j.tibs.2009.10.004 19959365
71. A highly stable duplex structure sequesters the 5' splice site region of hnRNP A1 alternative exon 7B. Blanchette M, Chabot B, RNA 1997 3 4 405 419 9085847
72. Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes. Singh NN, Singh RN, Androphy EJ, Nucleic Acids Res 2007 35 2 371 389 17170000
73. RNA secondary structure: an important cis-element in rat calcitonin/CGRP pre-messenger RNA splicing. Coleman TP, Roesser JR, Biochemistry 1998 37 45 15941 15950 10.1021/bi9808058 9843400
74. Non-Watson-Crick base pairs in RNA-protein recognition. Hermann T, Westhof E, Chem Biol 1999 6 12 335 R343 10.1016/S1074-5521(00)80003-4 10631510
75. Selection and design of high-affinity RNA ligands for HIV-1 Rev. Giver L, Bartel DP, Zapp ML, Green MR, Ellington AD, Gene 1993 137 1 19 24 10.1016/0378-1119(93)90246-Y 7506689
76. Structure of an RNA internal loop consisting of tandem C-A + base pairs. Jang SB, Hung LW, Chi YI, Holbrook EL, Carter RJ, Holbrook SR, Biochemistry 1998 37 34 11726 11731 10.1021/bi980758j 9718295
77. A Simple Fluorescence Method for pK(a) Determination in RNA and DNA Reveals Highly Shifted pK(a)'s. Wilcox JL, Bevilacqua PC, J Am Chem Soc 2013 135 20 7390 7393 10.1021/ja3125299 23432144
78. A CA(+) pair adjacent to a sheared GA or AA pair stabilizes size-symmetric RNA internal loops. Chen G, Kennedy SD, Turner DH, Biochemistry 2009 48 24 5738 5752 10.1021/bi8019405 19485416
79. Protonation of non-Watson-Crick base pairs and encapsidation of turnip yellow mosaic virus RNA. Bink HH, Hellendoorn K, van der Meulen J, Pleij CW, Proc Natl Acad Sci USA 2002 99 21 13465 13470 10.1073/pnas.202287499 12361978
80. Secondary structure of a conserved domain in the intron of influenza A NS1 mRNA. Priore SF, Kierzek E, Kierzek R, Baman JR, Moss WN, Dela-Moss LI, Turner DH, PloS ONE 2013 8 9 70615 10.1371/journal.pone.0070615 24023714
81. Evidence that the matrix protein of influenza C virus is coded for by a spliced mRNA. Yamashita M, Krystal M, Palese P, J Virol 1988 62 9 3348 3355 3404579
82. The transmembrane kinase Ire1p is a site-specific endonuclease that initiates mRNA splicing in the unfolded protein response. Sidrauski C, Walter P, Cell 1997 90 6 1031 1039 10.1016/S0092-8674(00)80369-4 9323131
83. Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display. Muro AF, Caputi M, Pariyarath R, Pagani F, Buratti E, Baralle FE, Mol Cell Biol 1999 19 4 2657 2671 10082532
84. RNA folding affects the recruitment of SR proteins by mouse and human polypurinic enhancer elements in the fibronectin EDA exon. Buratti E, Muro AF, Giombi M, Gherbassi D, Iaconcig A, Baralle FE, Mol Cell Biol 2004 24 3 1387 1400 10.1128/MCB.24.3.1387-1400.2004 14729981
85. Pre-mRNA secondary structures influence exon recognition. Hiller M, Zhang Z, Backofen R, Stamm S, PLoS Genet 2007 3 11 204 10.1371/journal.pgen.0030204 18020710
86. The influenza C virus CM2 protein can alter intracellular pH, and its transmembrane domain can substitute for that of the influenza A virus M2 protein and support infectious virus production. Stewart SM, Pekosz A, J Virol 2012 86 2 1277 1281 10.1128/JVI.05681-11 21917958
87. Role of the CM2 protein in the influenza C virus replication cycle. Furukawa T, Muraki Y, Noda T, Takashita E, Sho R, Sugawara K, Matsuzaki Y, Shimotai Y, Hongo S, J Virol 2011 85 3 1322 1329 10.1128/JVI.01367-10 21106743
88. Characterization of a second protein (CM2) encoded by RNA segment 6 of influenza C virus. Hongo S, Sugawara K, Muraki Y, Kitame F, Nakamura K, J Virol 1997 71 4 2786 2792 9060633
89. The CM2 protein of influenza C virus is an oligomeric integral membrane glycoprotein structurally analogous to influenza A virus M2 and influenza B virus NB proteins. Pekosz A, Lamb RA, Virology 1997 237 2 439 451 10.1006/viro.1997.8788 9356355
90. Identification of a second protein encoded by influenza C virus RNA segment 6. Hongo S, Sugawara K, Nishimura H, Muraki Y, Kitame F, Nakamura K, J Gen Virol 1994 75 Pt 12 3503 3510 7996141
91. Influenza C virus CM2 integral membrane glycoprotein is produced from a polypeptide precursor by cleavage of an internal signal sequence. Pekosz A, Lamb RA, Proc Natl Acad Sci USA 1998 95 22 13233 13238 10.1073/pnas.95.22.13233 9789071
92. Influenza C virus CM2 protein is produced from a 374-amino-acid protein (P42) by signal peptidase cleavage. Hongo S, Sugawara K, Muraki Y, Matsuzaki Y, Takashita E, Kitame F, Nakamura K, J Virol 1999 73 1 46 50 9847305
93. Poliovirus neurovirulence correlates with the presence of a cryptic AUG upstream of the initiator codon. Slobodskaya OR, Gmyl AP, Maslova SV, Tolskaya EA, Viktorova EG, Agol VI, Virology 1996 221 1 141 150 10.1006/viro.1996.0360 8661422
94. Cryptic AUG is important for 48S ribosomal assembly during internal initiation of translation of coxsackievirus B3 RNA. Verma B, Ponnuswamy A, Gnanasundram SV, Das S, J Gen Virol 2011 92 Pt 10 2310 2319 21733885
95. Secondary structure of mouse and rabbit alpha- and beta-globin mRNAs: differential accessibility of alpha and beta initiator AUG codons towards nucleases. Pavlakis GN, Lockard RE, Vamvakopoulos N, Rieser L, RajBhandary UL, Vournakis JN, Cell 1980 19 1 91 102 10.1016/0092-8674(80)90391-8 7357610
96. Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Kozak M, Gene 2005 361 13 37 16213112
97. Coding-sequence determinants of gene expression in Escherichia coli. Kudla G, Murray AW, Tollervey D, Plotkin JB, Science 2009 324 5924 255 258 10.1126/science.1170160 19359587
98. The 3' splice site of influenza A segment 7 mRNA can exist in two conformations: a pseudoknot and a hairpin. Moss WN, Dela-Moss LI, Kierzek E, Kierzek R, Priore SF, Turner DH, PLoS ONE 2012 7 6 38323 10.1371/journal.pone. 0038323 22685560
99. The influenza A segment 7 mRNA 3' splice site pseudoknot/hairpin family. Moss WN, Dela-Moss LI, Priore SF, Turner DH, RNA Biol 2012 9 11 1305 1310 10.4161/rna.22343 23064116
100. The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing. Warf MB, Diegel JV, von Hippel PH, Berglund JA, Proc Natl Acad Sci USA 2009 106 23 9203 9208 10.1073/pnas.0900342106 19470458
101. Regulation of alternative splicing by the ATP-dependent DEAD-box RNA helicase p72. Honig A, Auboeuf D, Parker MM, O'Malley BW, Berget SM, Mol Cell Biol 2002 22 16 5698 5707 10.1128/MCB.22.16.5698-5707.2002 12138182
102. Control of alternative RNA splicing and gene expression by eukaryotic riboswitches. Cheah MT, Wachter A, Sudarsan N, Breaker RR, Nature 2007 447 7143 497 500 10.1038/nature05769 17468745
103. Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression. Winkler W, Nahvi A, Breaker RR, Nature 2002 419 6910 952 956 10.1038/nature01145 12410317
104. Identification of cis-acting intron and exon regions in influenza virus NS1 mRNA that inhibit splicing and cause the formation of aberrantly sedimenting presplicing complexes. Nemeroff ME, Utans U, Kramer A, Krug RM, Mol Cell Biol 1992 12 3 962 970 1532050
105. In vitro splicing of influenza viral NS1 mRNA and NS1-beta-globin chimeras: possible mechanisms for the control of viral mRNA splicing. Plotch SJ, Krug RM, Proc Natl Acad Sci U S A 1986 83 15 5444 5448 10.1073/pnas.83.15.5444 3461442
106. Targeting RNA splicing for disease therapy. Havens MA, Duelli DM, Hastings ML, Wiley Interdiscip Rev RNA 2013
107. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules. Mei HY, Cui M, Heldsinger A, Lemrow SM, Loo JA, Sannes-Lowery KA, Sharmeen L, Czarnik AW, Biochemistry 1998 37 40 14204 14212 10.1021/bi981308u 9760258
108. RNA as a target for small molecules. Sucheck SJ, Wong CH, Curr Opin Chem Biol 2000 4 6 678 686 10.1016/S1367-5931(00)00142-3 11102874
109. Targeting RNA with small molecules. Wilson WD, Li K, Curr Med Chem 2000 7 1 73 98 10.2174/0929867003375434 10637358
110. Two-dimensional combinatorial screening identifies specific aminoglycoside-RNA internal loop partners. Disney MD, Labuda LP, Paul DJ, Poplawski SG, Pushechnikov A, Tran T, Velagapudi SP, Wu M, Childs-Disney JL, J Am Chem Soc 2008 130 33 11185 11194 10.1021/ja803234t 18652457
111. Small molecule microarrays of RNA-focused peptoids help identify inhibitors of a pathogenic group I intron. Labuda LP, Pushechnikov A, Disney MD, ACS Chem Biol 2009 4 4 299 307 10.1021/cb800313m 19278238
112. Oligonucleotide directed misfolding of RNA inhibits Candida albicans group I intron splicing. Childs JL, Disney MD, Turner DH, Proc Natl Acad Sci USA 2002 99 17 11091 11096 10.1073/pnas.172391199 12169671
113. New approaches to targeting RNA with oligonucleotides: inhibition of group I intron self-splicing. Disney MD, Childs JL, Turner DH, Biopolymers 2004 73 1 151 161 10.1002/bip.10520 14691946
114. Binding of short oligonucleotides to RNA: studies of the binding of common RNA structural motifs to isoenergetic microarrays. Kierzek E, Biochemistry 2009 48 48 11344 11356 10.1021/bi901264v 19835418
115. Aptamers targeting RNA molecules. Watrin M, Dausse E, Lebars I, Rayner B, Bugaut A, Toulme JJ, Methods Mol Biol 2009 535 79 105 10.1007/978-1-59745-557- 2-6 19377979